Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
4-phenethyl-1-propargylpiperidine-derived dual inhibitors of butyrylcholinesterase and monoamine oxidase B
ID
Mazej, Tjaša
(
Author
),
ID
Knez, Damijan
(
Author
),
ID
Meden, Anže
(
Author
),
ID
Gobec, Stanislav
(
Author
),
ID
Sova, Matej
(
Author
)
PDF - Presentation file,
Download
(3,88 MB)
MD5: 4EFBA46D5CF134616B4593732FBD48D3
URL - Source URL, Visit
https://www.mdpi.com/1420-3049/26/14/4118
Image galllery
Abstract
The multi-target-directed ligands (MTDLs) strategy is encouraged for the development of novel modulators targeting multiple pathways in the neurodegenerative cascade typical for Alzheimer’s disease (AD). Based on the structure of an in-house irreversible monoamine oxidase B (MAO-B) inhibitor, we aimed to introduce a carbamate moiety on the aromatic ring to impart cholinesterase (ChE) inhibition, and to furnish multifunctional ligands targeting two enzymes that are intricately involved in AD pathobiology. In this study, we synthesized three dual hMAO-B/hBChE inhibitors 13–15, with compound 15 exhibiting balanced, low micromolar inhibition of hMAO-B (IC$_{50}$ of 4.3 µM) and hBChE (IC$_{50}$ of 8.5 µM). The docking studies and time-dependent inhibition of hBChE confirmed the initial expectation that the introduced carbamate moiety is responsible for covalent inhibition. Therefore, dual-acting compound 15 represents an excellent starting point for further optimization of balanced MTDLs.
Language:
English
Keywords:
Alzheimer's disease
,
butyrylcholinesterase
,
monoamine oxidase B
,
inhibitors
,
multi-target-directed ligands
,
multifunctional ligands
Work type:
Article
Typology:
1.01 - Original Scientific Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2021
Number of pages:
17 str.
Numbering:
Vol. 26, iss. 14, art. 4118
PID:
20.500.12556/RUL-135594
UDC:
615.4:54:616.894
ISSN on article:
1420-3049
DOI:
10.3390/molecules26144118
COBISS.SI-ID:
69610499
Publication date in RUL:
21.03.2022
Views:
1720
Downloads:
152
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Molecules
Shortened title:
Molecules
Publisher:
MDPI
ISSN:
1420-3049
COBISS.SI-ID:
18462981
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:
06.07.2021
Secondary language
Language:
Slovenian
Keywords:
butirilholinesteraze
,
zaviralci
,
monoamin oksidaza B
,
večfunkcijski ligandi
,
tarčni ligandi
,
Alzheimerjeva bolezen
,
farmacevtska kemija
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
Z1-1859
Name:
Kovalentni zaviralci: zaviranje monoamin oksidaze preko nekatalitskih aminokislinskih ostankov
Funder:
ARRS - Slovenian Research Agency
Project number:
L1-8157
Name:
Razvoj multifunkcionalnih učinkovin za zdravljenje Alzheimerjeve bolezni
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back